Detalhe da pesquisa
1.
Clinical implementation of pre-treatment DPYD genotyping in capecitabine-treated metastatic breast cancer patients.
Breast Cancer Res Treat
; 175(2): 511-517, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30746637
2.
Target-based therapeutic matching of phase I trials in patients with metastatic breast cancer in a tertiary referral centre.
Br J Cancer
; 119(8): 922-927, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30318518
3.
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial.
JAMA Oncol
; 10(4): 475-483, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38358753
4.
Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity.
Radiology
; 265(2): 426-36, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22891356
5.
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717027
6.
Revisiting the role of antiandrogen strategies in ovarian cancer.
Oncologist
; 16(10): 1413-21, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21948654
7.
Outcomes of patients with metastatic melanoma treated with molecularly targeted agents in phase I clinical trials.
Oncology
; 81(2): 135-40, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21985828
8.
Revisiting the role of molecular targeted therapies in patients with brain metastases.
J Neurooncol
; 105(3): 467-74, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21785914
9.
Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer.
Lung Cancer
; 161: 55-59, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536732
10.
First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors.
Clin Cancer Res
; 26(18): 4777-4784, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616501
11.
Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit.
Eur J Cancer
; 75: 56-62, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28214659
12.
Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS.
Expert Rev Anticancer Ther
; 13(5): 559-67, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23617347
13.
Targeting brain metastases in patients with melanoma.
Biomed Res Int
; 2013: 186563, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24455677
14.
A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors.
Clin Cancer Res
; 18(9): 2687-94, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22553374
15.
Baseline circulating tumor cell counts significantly enhance a prognostic score for patients participating in phase I oncology trials.
Clin Cancer Res
; 17(15): 5188-96, 2011 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21531820
16.
Toward a better dialogue between neuro-oncologists and phase I investigators.
J Clin Oncol
; 30(5): 562-3; author reply 563-4, 2012 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22215743